| Serial Number | 78851363 |
| Word Mark | MIVURA |
| Filing Date | Friday, March 31, 2006 |
| Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
| Status Date | Monday, March 21, 2011 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, November 27, 2007 |
| Goods and Services | Pharmaceutical preparations and substances for the prevention, treatment and alleviation of stress; pharmaceutical preparations and substances for the prevention, treatment and alleviation of diabetes; pharmaceutical preparations and substances for controlling insulin levels; pharmaceutical preparations and substances for the prevention, treatment and alleviation of hypertension; pharmaceutical preparations and substances for the prevention, treatment and alleviation of angina; pharmaceutical preparations and substances for the cessation of smoking; pharmaceutical preparations and substances for the prevention and treatment of sexually transmitted diseases; pharmaceutical preparations and substances for the prevention and treatment of herpes; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the central nervous system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of depression; anti-depressants; pharmaceutical preparations and substances for the prevention, treatment and alleviation of sleep disorders; pharmaceutical preparations and substances for the prevention, treatment and alleviation of anxiety; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the cardio-vascular system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of acute myocardial infarctions; pharmaceutical preparations and substances for the prevention, treatment and alleviation of symptomatic congestive heart failure; pharmaceutical preparations and substances for the prevention, treatment and alleviation of asymptomatic left ventricular dysfunction; pharmaceutical preparations and substances, namely, fibrinolytic or thrombolytic agents; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the respiratory system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the endocrine system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the immune system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the musculo-skeletal system, namely, bone diseases and bone degenerative conditions; pharmaceutical preparations and substances for the prevention, treatment and alleviation of pain and inflammation, namely, pain relief medication and anti-inflammatories; pharmaceutical preparations and substances for the prevention, treatment and alleviation of migraines; pharmaceutical preparations and substances, namely, medicated skin care preparations for use in dermatology, namely, dermatitis and skin pigmentation diseases; pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations and substances for use in ophthalmology; pharmaceutical preparations and substances for the treatment of polycystic ovary syndrome; pharmaceutical preparations and substances for the treatment of infertility; pharmaceutical preparations and substances for the prevention, treatment and alleviation of circulatory, neurologic, alimentary, auto-immune, pulmonary, musculoskeletal, lymphatic, gastrointestinal, bone sensory, viral, urinary, renal, infectious or metabolic diseases, illnesses, disorders or conditions; metformin; diltiazem; tramadol; carvedilol; bupropion; metoprolol; citalopram; zolpidem; fluoxetine; venlafaxine; lorazepam; and sumatriptan |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, April 6, 2006 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Biovail Laboratories International SRL |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | Christ Church BB17154 BB |
| Party Name | Biovail Laboratories International SRL |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | St. Michael BB |
| Event Date | Event Description |
| Wednesday, January 22, 2014 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Wednesday, January 22, 2014 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Wednesday, March 23, 2011 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| Monday, March 21, 2011 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED |
| Monday, March 21, 2011 | ABANDONMENT - NO USE STATEMENT FILED |
| Wednesday, October 13, 2010 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| Wednesday, August 25, 2010 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, August 24, 2010 | EXTENSION 5 GRANTED |
| Monday, August 16, 2010 | EXTENSION 5 FILED |
| Monday, August 16, 2010 | TEAS EXTENSION RECEIVED |
| Thursday, February 11, 2010 | EXTENSION 4 GRANTED |
| Thursday, February 4, 2010 | EXTENSION 4 FILED |
| Thursday, February 4, 2010 | TEAS EXTENSION RECEIVED |
| Thursday, August 13, 2009 | EXTENSION 3 GRANTED |
| Wednesday, August 12, 2009 | EXTENSION 3 FILED |
| Wednesday, August 12, 2009 | TEAS EXTENSION RECEIVED |
| Wednesday, June 17, 2009 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| Tuesday, March 3, 2009 | EXTENSION 2 GRANTED |
| Friday, February 13, 2009 | EXTENSION 2 FILED |
| Tuesday, March 3, 2009 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Friday, February 13, 2009 | TEAS EXTENSION RECEIVED |
| Thursday, January 22, 2009 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Thursday, January 22, 2009 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Tuesday, August 12, 2008 | EXTENSION 1 GRANTED |
| Tuesday, August 12, 2008 | EXTENSION 1 FILED |
| Tuesday, August 12, 2008 | TEAS EXTENSION RECEIVED |
| Tuesday, February 19, 2008 | NOA MAILED - SOU REQUIRED FROM APPLICANT |
| Friday, December 7, 2007 | CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED |
| Friday, November 30, 2007 | FAX RECEIVED |
| Tuesday, November 27, 2007 | PUBLISHED FOR OPPOSITION |
| Wednesday, November 7, 2007 | NOTICE OF PUBLICATION |
| Friday, October 19, 2007 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Friday, October 19, 2007 | ASSIGNED TO LIE |
| Saturday, September 29, 2007 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Tuesday, September 18, 2007 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Thursday, September 13, 2007 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, September 12, 2007 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, September 12, 2007 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Wednesday, September 12, 2007 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| Wednesday, March 14, 2007 | FINAL REFUSAL E-MAILED |
| Wednesday, March 14, 2007 | FINAL REFUSAL WRITTEN |
| Tuesday, March 13, 2007 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, March 13, 2007 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, March 13, 2007 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, September 19, 2006 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Wednesday, September 13, 2006 | NON-FINAL ACTION E-MAILED |
| Wednesday, September 13, 2006 | NON-FINAL ACTION WRITTEN |
| Wednesday, September 13, 2006 | ASSIGNED TO EXAMINER |
| Thursday, April 6, 2006 | NEW APPLICATION ENTERED IN TRAM |